Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome

Abstract. Background:. Obesity and insulin resistance (IR) are common features of polycystic ovary syndrome (PCOS). Metformin (MET) increases insulin sensitivity, but it is associated with unsatisfactory weight loss. The glucagon-like peptide-1 receptor agonist exenatide has been shown to reduce wei...

Full description

Bibliographic Details
Main Authors: Rui-Lin Ma, Yan Deng, Yan-Fang Wang, Shi-Yang Zhu, Xue-Song Ding, Ai-Jun Sun, Yan-Jie Yin, Xiu-Yuan Hao
Format: Article
Language:English
Published: Wolters Kluwer 2021-12-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001712

Similar Items

Similar Items